The pathology of non-Hodgkin's lymphoma of childhood

II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's)

J. F. Wilson, C. R. Kjeldsberg, R. Sposto, R. D.T. Jenkin, R. R. Chilcote, Peter Felix Coccia, R. R. Exelby, J. Kersey, A. Meadows, S. Siegel, D. Hammond

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The Children's Cancer Study Group conducted prospective clinical trials of 608 children with non-Hodgkin's lymphoma from 1977 to 1983. In 1980, significant differences in survival of children with disseminated disease correlated with histologic diagnosis and the randomized treatment employed. A pathology reproducbility review showed the lymphoblastic lymphoma cases to be virtually 100 per cent distinguishable histologically from the nonlymphoblastic lymphomas (Burkitt's, non-Burkitt's and "histiocytic"). However, diagnostic reproducibility of the pathologist-of-record was 59 per cent in the Burkitt's and non-Burkitt's lymphoma group. Therefore, 159 cases, agreed on by the pathologist-of-record and the "lymphoma panel" as Burkitt's (77 cases) or non-Burkitt's lymphoma (82, cases) and designated as the "reference diagnosis," were blindly reviewed twice each by two hematopathologists to yield the "review diagnoses". Consensus agreement was achieved in 67 per cent of cases overall, 82 per cent of Burkitt's and 54 per cent of non-Burkitt's lymphoma. Using the "reference diagnoses," we found that the relative frequency of Burkitt's and non-Burkitt's lymphoma was associated with the extent of disease at diagnosis (P-0.06) but not with other prognostic factors. Despite the difficulties in histologic classification, analyses that used either "reference diagnoses" or "consensus review diagnoses" and that were adjusted for extent of disease consistently demonstrated significantly shorter event-free survival for patients having Burkitt's lymphoma; their failure rate was four times that for patient's with non-Burkitt's lymphoma. Newer cell biologic techniques, hopefully will enhance histopathologic distinctions that remain the basis for diagnosis.

Original languageEnglish (US)
Pages (from-to)1008-1014
Number of pages7
JournalHuman Pathology
Volume18
Issue number10
DOIs
StatePublished - Jan 1 1987

Fingerprint

Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
Pathology
Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Disease-Free Survival
Clinical Trials
Survival
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The pathology of non-Hodgkin's lymphoma of childhood : II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's). / Wilson, J. F.; Kjeldsberg, C. R.; Sposto, R.; Jenkin, R. D.T.; Chilcote, R. R.; Coccia, Peter Felix; Exelby, R. R.; Kersey, J.; Meadows, A.; Siegel, S.; Hammond, D.

In: Human Pathology, Vol. 18, No. 10, 01.01.1987, p. 1008-1014.

Research output: Contribution to journalArticle

Wilson, JF, Kjeldsberg, CR, Sposto, R, Jenkin, RDT, Chilcote, RR, Coccia, PF, Exelby, RR, Kersey, J, Meadows, A, Siegel, S & Hammond, D 1987, 'The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's)', Human Pathology, vol. 18, no. 10, pp. 1008-1014. https://doi.org/10.1016/S0046-8177(87)80217-4
Wilson, J. F. ; Kjeldsberg, C. R. ; Sposto, R. ; Jenkin, R. D.T. ; Chilcote, R. R. ; Coccia, Peter Felix ; Exelby, R. R. ; Kersey, J. ; Meadows, A. ; Siegel, S. ; Hammond, D. / The pathology of non-Hodgkin's lymphoma of childhood : II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's). In: Human Pathology. 1987 ; Vol. 18, No. 10. pp. 1008-1014.
@article{271e08a43170458f998a834794ad12df,
title = "The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of {"}undifferentiated{"} lymphomas (Burkitt's versus non-Burkitt's)",
abstract = "The Children's Cancer Study Group conducted prospective clinical trials of 608 children with non-Hodgkin's lymphoma from 1977 to 1983. In 1980, significant differences in survival of children with disseminated disease correlated with histologic diagnosis and the randomized treatment employed. A pathology reproducbility review showed the lymphoblastic lymphoma cases to be virtually 100 per cent distinguishable histologically from the nonlymphoblastic lymphomas (Burkitt's, non-Burkitt's and {"}histiocytic{"}). However, diagnostic reproducibility of the pathologist-of-record was 59 per cent in the Burkitt's and non-Burkitt's lymphoma group. Therefore, 159 cases, agreed on by the pathologist-of-record and the {"}lymphoma panel{"} as Burkitt's (77 cases) or non-Burkitt's lymphoma (82, cases) and designated as the {"}reference diagnosis,{"} were blindly reviewed twice each by two hematopathologists to yield the {"}review diagnoses{"}. Consensus agreement was achieved in 67 per cent of cases overall, 82 per cent of Burkitt's and 54 per cent of non-Burkitt's lymphoma. Using the {"}reference diagnoses,{"} we found that the relative frequency of Burkitt's and non-Burkitt's lymphoma was associated with the extent of disease at diagnosis (P-0.06) but not with other prognostic factors. Despite the difficulties in histologic classification, analyses that used either {"}reference diagnoses{"} or {"}consensus review diagnoses{"} and that were adjusted for extent of disease consistently demonstrated significantly shorter event-free survival for patients having Burkitt's lymphoma; their failure rate was four times that for patient's with non-Burkitt's lymphoma. Newer cell biologic techniques, hopefully will enhance histopathologic distinctions that remain the basis for diagnosis.",
author = "Wilson, {J. F.} and Kjeldsberg, {C. R.} and R. Sposto and Jenkin, {R. D.T.} and Chilcote, {R. R.} and Coccia, {Peter Felix} and Exelby, {R. R.} and J. Kersey and A. Meadows and S. Siegel and D. Hammond",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0046-8177(87)80217-4",
language = "English (US)",
volume = "18",
pages = "1008--1014",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - The pathology of non-Hodgkin's lymphoma of childhood

T2 - II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's)

AU - Wilson, J. F.

AU - Kjeldsberg, C. R.

AU - Sposto, R.

AU - Jenkin, R. D.T.

AU - Chilcote, R. R.

AU - Coccia, Peter Felix

AU - Exelby, R. R.

AU - Kersey, J.

AU - Meadows, A.

AU - Siegel, S.

AU - Hammond, D.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - The Children's Cancer Study Group conducted prospective clinical trials of 608 children with non-Hodgkin's lymphoma from 1977 to 1983. In 1980, significant differences in survival of children with disseminated disease correlated with histologic diagnosis and the randomized treatment employed. A pathology reproducbility review showed the lymphoblastic lymphoma cases to be virtually 100 per cent distinguishable histologically from the nonlymphoblastic lymphomas (Burkitt's, non-Burkitt's and "histiocytic"). However, diagnostic reproducibility of the pathologist-of-record was 59 per cent in the Burkitt's and non-Burkitt's lymphoma group. Therefore, 159 cases, agreed on by the pathologist-of-record and the "lymphoma panel" as Burkitt's (77 cases) or non-Burkitt's lymphoma (82, cases) and designated as the "reference diagnosis," were blindly reviewed twice each by two hematopathologists to yield the "review diagnoses". Consensus agreement was achieved in 67 per cent of cases overall, 82 per cent of Burkitt's and 54 per cent of non-Burkitt's lymphoma. Using the "reference diagnoses," we found that the relative frequency of Burkitt's and non-Burkitt's lymphoma was associated with the extent of disease at diagnosis (P-0.06) but not with other prognostic factors. Despite the difficulties in histologic classification, analyses that used either "reference diagnoses" or "consensus review diagnoses" and that were adjusted for extent of disease consistently demonstrated significantly shorter event-free survival for patients having Burkitt's lymphoma; their failure rate was four times that for patient's with non-Burkitt's lymphoma. Newer cell biologic techniques, hopefully will enhance histopathologic distinctions that remain the basis for diagnosis.

AB - The Children's Cancer Study Group conducted prospective clinical trials of 608 children with non-Hodgkin's lymphoma from 1977 to 1983. In 1980, significant differences in survival of children with disseminated disease correlated with histologic diagnosis and the randomized treatment employed. A pathology reproducbility review showed the lymphoblastic lymphoma cases to be virtually 100 per cent distinguishable histologically from the nonlymphoblastic lymphomas (Burkitt's, non-Burkitt's and "histiocytic"). However, diagnostic reproducibility of the pathologist-of-record was 59 per cent in the Burkitt's and non-Burkitt's lymphoma group. Therefore, 159 cases, agreed on by the pathologist-of-record and the "lymphoma panel" as Burkitt's (77 cases) or non-Burkitt's lymphoma (82, cases) and designated as the "reference diagnosis," were blindly reviewed twice each by two hematopathologists to yield the "review diagnoses". Consensus agreement was achieved in 67 per cent of cases overall, 82 per cent of Burkitt's and 54 per cent of non-Burkitt's lymphoma. Using the "reference diagnoses," we found that the relative frequency of Burkitt's and non-Burkitt's lymphoma was associated with the extent of disease at diagnosis (P-0.06) but not with other prognostic factors. Despite the difficulties in histologic classification, analyses that used either "reference diagnoses" or "consensus review diagnoses" and that were adjusted for extent of disease consistently demonstrated significantly shorter event-free survival for patients having Burkitt's lymphoma; their failure rate was four times that for patient's with non-Burkitt's lymphoma. Newer cell biologic techniques, hopefully will enhance histopathologic distinctions that remain the basis for diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0023205461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023205461&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(87)80217-4

DO - 10.1016/S0046-8177(87)80217-4

M3 - Article

VL - 18

SP - 1008

EP - 1014

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 10

ER -